Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Lorillard, Charter Communications, Synta Pharma

Tue, 31st Mar 2015 14:00

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stocks fell at the open on Tuesday, slightly reversing theprevious day's rally, though the S&P 500 remained on track forits ninth straight quarterly rise. The Dow Jones industrialaverage was down 0.55 percent at 17,876.78, the S&P 500 was down 0.45 percent at 2,076.79 and the NasdaqComposite was down 0.45 percent at 4,925.38.

** CHARTER COMMUNICATIONS INC, $195.28, +6.48 pct

Cable television operator Charter Communications Inc said it would buy Bright House Networks in acash-and-stock deal valued at $10.4 billion to expand inFlorida. Bright House, controlled by the Newhouse family, hasabout 2 million video customers in central Florida, includingOrlando and Tampa Bay as well as Alabama, Indiana, Michigan, andCalifornia.

** SYNTA PHARMACEUTICALS CORP, $1.96, -15.88 pct

The drug developer said it would commence a public offeringof common shares, but did not say when the offering would becompleted or provide any details on the number of shares orprice.

** VAALCO ENERGY INC, $2.68, -14.38 pct

The oil and gas producer said it is abandoning its firstwell drilled offshore Angola as it was found to bewater-bearing.

** TECK RESOURCES LTD, $14.14, -7.40 pct

The Canadian miner and Antofagasta Plc denied that they were in talks about a merger after Bloombergreported that the two mining companies were in early stagetalks. Teck said in a statement that it was not in discussionswith Antofagasta "in relation to any form of transaction."

** GLAXOSMITHKLINE PLC, $46.07, -2.39 pct

** JOHNSON & JOHNSON, $101.03, -0.51 pct

GlaxoSmithKline has agreed to settle a lawsuit byJohnson & Johnson accusing it of using false advertising at thestart of the U.S. allergy season to grab market share.

** CBRE GROUP INC, $38.89, +6.81 pct

** JOHNSON CONTROLS INC, $50.78, +1.91 pct

Johnson Controls, the largest U.S. auto parts maker, said itwould sell its business that helps corporations manage theirreal estate energy needs to real estate services firm CBRE Groupfor $1.48 billion in cash. CBRE, the world's largest commercialreal estate services firm, said it expects the deal to add toadjusted earnings in 2016.

** ENDURANCE SPECIALTY HOLDINGS LTD, $61.91, -3.72pct

** MONTPELIER RE HOLDINGS LTD, $38.49, +0.89 pct

Property and casualty insurer Endurance Specialty will buyreinsurer Montpelier Re for about $1.83 billion in cash andstock, to boost its Lloyd's of London underwriting business.Montpelier shareholders will get 0.472 Endurance share and $9.89in cash for each share held, the companies said on Tuesday. Thisrepresents $40.24 per share for Montpelier, a 5.5 percentpremium to the stock's closing on Monday.

** GW PHARMA PLC, $92.11, +4.20 pct

The British maker of cannabis-based drugs said ithas started the second leg of a mid-stage trial testingEpidiolex to treat Dravet syndrome, a rare, treatment-resistantform of childhood epilepsyelectronics. Data from the trial isexpected at end of year and GW expects to submit a marketingapplication to the FDA in mid-2016. Epidiolex will also undergolate-stage testing to treat Lennox-Gastaut syndrome.

** DRYSHIPS INC, $0.8233, +1.64 pct

The drybulk shipper agreed to sell its four Suezmax tankersfor about $245 million through its majority owned subsidiaryOcean Rig UDW Inc. The company also said it has entered into anagreement to potentially sell its six Aframax tankers for about$291 million.

** J C PENNEY CO INC, $8.18, +4.47 pct

Analysts at Piper Jaffray raised their price target on thedepartment store chain's stock to $14, according to SeekingAlpha. The brokerage also raised its estimates for the companybased on inventory channel checks, Seeking Alpha reported.

** PRICELINE GROUP INC, $1,165.8, +1.39 pct

Analysts at Stifel Nicolaus raised their rating on thetravel website operator to "buy" from "hold", saying thestabilizing European economy should help the company.

** REYNOLDS AMERICAN INC, $68.27, -1.73 pct

** LORILLARD INC, $65.35, -1.61 pct

The Federal Trade Commission staff is recommending a suit toblock the $27 billion merger of the second- and third-biggestcigarette makers, Reynolds American and Lorillard, the New YorkPost reported, citing a well-placed DC source not working on thecase said. (http://bit.ly/1xuMHLZ)

** INSMED INC, $20.91, -0.85 pct

The drug developer said it is offering 10 million shares ofits common stock, and intends to use the proceeds to developrespiratory drugs ARIKAYCE and INS1009.

** GROUPON INC, $7.3, -1.75 pct

** KKR & CO LP, $22.68, -0.40 pct

Private equity firms KKR and Hong Kong-based Anchor Partnersare in talks to buy a majority stake in Groupon's South Koreanunit for around 350 billion won ($316 million), a South Koreannewspaper reported on Tuesday.

($1 = 1,107.3200 won)

** BIOCRYST PHARMACEUTICALS INC, $8.87, +3.50 pct

The drug developer said it won a U.S. government contractfor the continued development of its potential treatment forviral diseases, including Ebola. The 18-month contract includesa base value of $12.1 million to support manufacturing, as wellas $22.9 million in additional development options that can beexercised by the government.

** MOSAIC CO, $46.64, -1.52 pct

The U.S. fertilizer company said it would raise its annualdividend by 10 cents to $1.10 per share, effective in May. Themove comes despite recent tax changes by the Canadian provinceof Saskatchewan, where Mosaic mines the crop nutrient potash,which the company said earlier would cost it $80 million to $100million in 2015.

** INTERNATIONAL BUSINESS MACHINES CORP, $161.08,-0.98 pct

The company said it would invest $3 billion over the nextfour years in a new 'Internet of Things' unit, aiming to sellits expertise in gathering and making sense of the surge inreal-time data.

** CITIGROUP INC, $51.34, -0.58 pct

The U.S. bank has agreed to sell its credit card unit inJapan to Sumitomo Mitsui Trust Bank, the companies said onTuesday, as Citi slims down globally to bolster itsprofitability.

** CONOCOPHILLIPS, $63.15, -1.33 pct

The American oil company plans to invest about $2.5 billionin Indonesia's upstream oil and gas industry over the next threeor four years, the nation's energy minister said on Tuesday.

** EXXON MOBIL CORP, $84.87, -0.89 pct

The oil and gas producer said it started production in thedeepwater Gulf of Mexico at Hadrian South, its deepest subseatie-back. The daily gross production from the project isexpected to reach about 300 mln cubic feet of gas and 3,000barrels of liquids from two wells.

** COMCAST CORP, $56.27, -0.60 pct

The largest U.S. cable operator said it would form a newcompany with its chief financial officer, Michael Angelakis, toinvest in and focus on operating growth-oriented companies bothin the United States and international markets. The new companywould have total capital commitments of up to $4.1 billion, ofwhich $4 billion will be invested by Comcast. At least $40million will be invested by Angelakis.

** SPRINT CORP, $4.72, -0.63 pct

Sprint has agreed to settle a $131 million lawsuit accusingit of defrauding shareholders by issuing false and misleadingstatements about its tightened credit standards, improvements inits subscriber base, and the success of its merger with NextelCommunications Inc. (Compiled by Ramkumar Iyer in Bengaluru; Editing by SimonJennings)

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.